Announcements Trials
Browse Landscape

Phase

Phase 2 64Phase 3 26Phase NA 14Phase 2/3 5Phase 1/2 4Phase EARLY_PHASE1 2Phase 4 2Phase 1 2

Status

Unknown 5Completed 4Not yet recruiting 3Withdrawn 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1

Conditions

Oesophagogastric Cancer 1Esophageal Squamous Cell Carcinoma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Neoadjuvant Therapy × Clear all
NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

National Taiwan University Hospital

Phase 2/3 Unknown
248 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04968002 2021-07-20

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer: A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2/3 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04025437 2019-09-04

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Guangxi Medical University

Phase 2/3 Unknown
214 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown
1,103 enrolled
Gastrointestinal

Oesophagogastric Cancer

NCT02882269 2016-08-30

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2/3 Unknown
400 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡